Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2022
Bismuth Nanoparticle and Polyhydroxybutyrate Coatings Enhance the Radiopacity of Absorbable Inferior Vena Cava Filters for Fluoroscopy-Guided Placement and Longitudinal Computed Tomography Monitoring in Pigs, Jossana A Damasco, Steven Y Huang, Joy Vanessa D Perez, et al.
A Narrative Review on Invasive Brain Stimulation for Treatment-Resistant Depression, Manoj P Dandekar, Alexandre P Diaz, Ziaur Rahman, et al.
Genetic Studies on Mammalian DNA Methyltransferases, Jiameng Dan and Taiping Chen
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors, Matthew Dankner, Yifan Wang, Rouhi Fazelzad, et al.
Emergence of Clinical Clostridioides Difficile Isolates With Decreased Susceptibility to Vancomycin, Charles Darkoh, Kadiatou Keita, Chioma Odo, et al.
A Novel Proton-Integrating Radiography System Design Using a Monolithic Scintillator Detector: Experimental Studies, Chinmay D Darne, Daniel G Robertson, Fahed Alsanea, et al.
Estimating the Optimal Linear Combination of Predictors Using Spherically Constrained Optimization, Priyam Das, Debsurya De, Raju Maiti, et al.
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions, Naval G Daver, Abhishek Maiti, Tapan M Kadia, et al.
Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer, Jennifer S Davis, Janelle C Chavez, Melissa Kok, et al.
Current Surgical Indications for Non-Small-Cell Lung Cancer, Nathaniel Deboever, Kyle G Mitchell, Hope A Feldman, et al.
Neoadjuvant Chemo-Immunotherapy for Lung Cancer: How Much Is Too Much?, Nathaniel Deboever and Jianjun Zhang
Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy, Brian De, Kelsey L Corrigan, Michael K Rooney, et al.
Patients' Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer, Brian De, Lisa M Lowenstein, Kelsey L Corrigan, et al.
Definitive Radiotherapy for Extracranial Oligoprogressive Metastatic Renal Cell Carcinoma as a Strategy to Defer Systemic Therapy Escalation, Brian De, Aradhana M Venkatesan, Pavlos Msaouel, et al.
The Genomic Alterations in Glioblastoma Influence the Levels of CSF Metabolites, Wilfredo De Jesús-Rojas, José Muñiz-Hernández, Francisco Alvarado-Huerta, et al.
Feasibility of Administering Human Pancreatic Cancer Chemotherapy in a Spontaneous Pancreatic Cancer Mouse Model, Abagail M Delahoussaye, Joseph Abi Jaoude, Morgan Green, et al.
Triple Blockade of Ido-1, PD-L1 and MEK as a Potential Therapeutic Strategy in NSCLC, Carminia Maria Della Corte, Vincenza Ciaramella, Kavya Ramkumar, et al.
Anti-Tumor Activity of Cetuximab Plus Avelumab in Non-Small Cell Lung Cancer Patients Involves Innate Immunity Activation: Findings From the CAVE-Lung Trial, Carminia Maria Della Corte, Morena Fasano, Vincenza Ciaramella, et al.
Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 In Vitro: Rationale for a Host-Acting Antiviral Treatment Strategy for COVID-19, James F Demarest, Maryline Kienle, RuthMabel Boytz, et al.
Loss of LAMP5 Interneurons Drives Neuronal Network Dysfunction in Alzheimer’s Disease, Yuanyuan Deng, Mian Bi, Fabien Delerue, et al.
Resistance to Targeted Therapies: Delving Into FLT3 and IDH, Sai Prasad Desikan, Naval Daver, Courtney DiNardo, et al.
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci, Amber A DeVries, Joe Dennis, Jonathan P Tyrer, et al.
Consistency of Efficacy Results Across Various Clinical Measures and Statistical Methods in the Lecanemab Phase 2 Trial of Early Alzheimer’s Disease, Shobha Dhadda, Michio Kanekiyo, David Li, et al.
Identity-Related Experiences of Asian American Trainees in Gynecologic Oncology, Jhalak Dholakia, Yeon Woo Lee, Karen H Lu, et al.
A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers, Adi Diab, Omid Hamid, John A Thompson, et al.